CPhI Conference: Generics and Biosimilars Strategies EMEA
LONDON, June 9, 2011 /PRNewswire/ --
- Strengthening Your Global Position and Protecting Margins Through Expansion, Innovation and Differentiation
- 27-28 September 2011, Istanbul, Turkey
CPhI Conferences, part of the team responsible for CPhI Worldwide, is hosting a new two-day conference for the international pharmaceutical community offering business-focused insight on how to succeed in the generics and biosimilars markets.
With it estimated that drugs worth nearly $25 billion in sales will come off patent in 2011, interest in future opportunities for generics and biosimilars are high. But with ongoing pricing pressures and the continuing consolidation of the market, companies are looking to emerging markets, differentiation strategies and innovations in super-generics and biosimilars for future growth.
Given global interest in Turkey's booming generics market and its position at the heart of EMEA, holding this event in Istanbul will provide a valuable business and networking opportunity to delegates from across the region.
CPhI are delighted to be working in association with the Turkish Pharmaceutical Manufacturers Association (IEIS). Mr. Nezih Barut , Chairman of IEIS says: "I am sure attendees will not only make use of the new information and networking possibilities that the conference will bring together, but will also have the chance to explore what Istanbul has to offer to its visitors. As the leading organisation in the Turkish pharmaceutical industry, we consider this CPhI conference as an important event and therefore provide our support"
CPhI Conferences will be bringing together an international panel of expert speakers primarily representing big pharma, generics, biosimilars and consultancy companies. Over the course of the two days they will be offering delegates insights on strategy, business development, marketing, regulation, innovation and more.
Uniquely, the afternoon of Day 2 will be dedicated to exploring the challenges and opportunities presented by the Turkish market and examine the pricing, legal, regulatory and business realities of operating there. For those with an eye on Turkey's booming consumer market, it will be an invaluable opportunity to meet key players.
Please visit http://www.generics-emea.com for more information and to see the agenda.
Tickets for the conference are EUR1099 for the Full 2 day conference, EUR399 for the Turkey Masterclass only and EUR275 for the Post-Conference Workshop. Group booking discounts are available - please contact +44(0)20-7921-8039 or firstname.lastname@example.org for additional information.
SOURCE CPhI Conferences
More by this Source
How Do Industry Experts See the Future Development of the Pharmaceutical Cold Chain?
Apr 23, 2013, 08:00 ET
Free Download for Pharma Cold Chain Management
Apr 08, 2013, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.